Beam Therapeutics
(NASDAQ:BEAM)
$34.30
-1.11[-3.13%]
At close: Mar 18
$34.30
0[0.00%]
After Hours: 5:48PM EDT

GET A REPORT ON BEAM SENT RIGHT TO YOUR INBOX

75%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
60
0100

Beam Therapeutics Stock (NASDAQ:BEAM), Quotes and News Summary

Beam Therapeutics Stock (NASDAQ: BEAM) stock price, news, charts, stock research, profile.
Open$35.400
Close$34.065
Volume / Avg.930.519K / 1.481M
Day Range34.030 - 35.720
52 Wk Range16.950 - 49.500
Market Cap$2.801B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
48
Short Interest
20.85%
Days to Cover9.09
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Oct 23
1
Dec 23
1
Jan
1
Feb
1
Strong Buy
Buy
Hold
Sell
Strong Sell
About Beam Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its ...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BEAM
IDYA

FAQ

Q

How do I buy Beam Therapeutics (BEAM) stock?

A

You can purchase shares of Beam Therapeutics (NASDAQ: BEAM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Beam Therapeutics's (BEAM) competitors?

Q

What is the target price for Beam Therapeutics (BEAM) stock?

A

The latest price target for Beam Therapeutics (NASDAQ: BEAM) was reported by Barclays on Wednesday, February 28, 2024. The analyst firm set a price target for 42.00 expecting BEAM to rise to within 12 months (a possible 22.45% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Beam Therapeutics (BEAM)?

A

The stock price for Beam Therapeutics (NASDAQ: BEAM) is $34.3 last updated March 18, 2024 at 5:48 PM EDT.

Q

Does Beam Therapeutics (BEAM) pay a dividend?

A

A quarterly cash dividend of $0.23 per share of Class A Common Stock. The quarterly cash dividend was payable on March 3, 2014 to stockholders of record on February 4, 2014.

Q

When is Beam Therapeutics (NASDAQ:BEAM) reporting earnings?

A

Beam Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Q

Is Beam Therapeutics (BEAM) going to split?

A

There is no upcoming split for Beam Therapeutics.

Q

What sector and industry does Beam Therapeutics (BEAM) operate in?

A

Beam Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch